Nm23-H1 can induce cell cycle arrest and apoptosis in B cells

Cancer Biology and Therapy

Volumn 9, Issue 12, 2010, Pages 1065-1078

  Choudhuri, Tathagata ^a,b   Murakami, Masanao ^b,c   Kaul, Rajeev ^b,d   Sahu, Sushil K ^a   Mohanty, Suchitra ^a   Verma, Subhash C ^b,e   Kumar, Pankaj ^b,f   Robertson, Erle S ^b  

^a INSTITUTE OF LIFE SCIENCES   (India)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c KOCHI WOMEN S UNIVERSITY   (Japan)

^d UNIVERSITY OF DELHI   (India)

^e UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

B cells; Cyclin D1; Nm23 H1; Oligo GE array; p53

Indexed keywords

ADENOSINE TRIPHOSPHATE; BETA ACTIN; CASPASE 3; CASPASE 9; CYCLIN D1; CYCLINE; NUCLEOSIDE DIPHOSPHATE KINASE; NUCLEOSIDE DIPHOSPHATE KINASE A; NUCLEOSIDE DIPHOSPHATE SUGAR; NUCLEOSIDE TRIPHOSPHATE; PROTEIN BAX; PROTEIN BCL XL; PROTEIN P21; PROTEIN P53; TRANSCRIPTION FACTOR AP 1;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; COMPLEX FORMATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UPREGULATION; VALIDATION PROCESS;

APOPTOSIS; B-LYMPHOCYTES; BURKITT LYMPHOMA; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE, TUMOR; DOWN-REGULATION; GENE EXPRESSION PROFILING; GENES, P53; HUMANS; NM23 NUCLEOSIDE DIPHOSPHATE KINASES; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 77954413145     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.9.12.11995     Document Type: Article

References (59)

1. Lacombe ML, Milon L, Munier A, Mehus JG, Lambeth DO. The human Nm23/nucleoside diphosphate kinases. J Bioenerg Biomembr 2000; 32:247-58.
2. Parks RE Jr, Brown PR, Cheng YC, Agarwal KC, Kong CM, Agarwal RP, Parks CC. Purine metabolism in primitive erythrocytes. Comp Biochem Physiol B 1973; 45:355-64.
3. Rosengard AM, Krutzsch HC, Shearn A, Biggs JR, Barker E, Margulies IM, et al. Reduced Nm23/Awd protein in tumour metastasis and aberrant Drosophila development. Nature 1989; 342:177-80.
4. Cipollini G, Berti A, Fiore L, Rainaldi G, Basolo F, Merlo G, et al. Downregulation of the nm23.h1 gene inhibits cell proliferation. Int J Cancer 1997; 73:297-302.
5. Lakso M, Steeg PS, Westphal H. Embryonic expression of nm23 during mouse organogenesis. Cell Growth Differ 1992; 3:873-9.
6. Steeg PS, Bevilacqua G, Pozzatti R, Liotta LA, Sobel ME. Altered expression of NM23, a gene associated with low tumor metastatic potential, during adenovirus 2 Ela inhibition of experimental metastasis. Cancer Res 1988; 48:6550-4.
7. Boissan M, Beurel E, Wendum D, Rey C, Lecluse Y, Housset C, et al. Overexpression of insulin receptor substrate-2 in human and murine hepatocellular carcinoma. Am J Pathol 2005; 167:869-77.
8. Boissan M, Wendum D, Arnaud-Dabernat S, Munier A, Debray M, Lascu I, et al. Increased lung metastasis in transgenic NM23-Null/SV40 mice with hepatocellular carcinoma. J Natl Cancer Inst 2005; 97:836-45. (Pubitemid 40909126)
9. Leone A, Flatow U, VanHoutte K, Steeg PS. Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity. Oncogene 1993; 8:2325-33. (Pubitemid 23252360)
10. Steeg PS, de la Rosa A, Flatow U, MacDonald NJ, Benedict M, Leone A. Nm23 and breast cancer metastasis. Breast Cancer Res Treat 1993; 25:175-87.
11. Kaul R, Murakami M, Choudhuri T, Robertson ES. Epstein-Barr virus latent nuclear antigens can induce metastasis in a nude mouse model. J Virol 2007; 81:10352-61. (Pubitemid 47463310)
12. Freije JM, Blay P, MacDonald NJ, Manrow RE, Steeg PS. Site-directed mutation of Nm23-H1. Mutations lacking motility suppressive capacity upon transfection are deficient in histidine-dependent protein phosphotransferase pathways in vitro. J Biol Chem 1997; 272:5525-32. (Pubitemid 27102375)
13. MacDonald NJ, Freije JM, Stracke ML, Manrow RE, Steeg PS. Site-directed mutagenesis of nm23-H1. Mutation of proline 96 or serine 120 abrogates its motility inhibitory activity upon transfection into human breast carcinoma cells. J Biol Chem 1996; 271:25107-16.
14. Horak CE, Mendoza A, Vega-Valle E, Albaugh M, Graff-Cherry C, McDermott WG, et al. Nm23-H1 suppresses metastasis by inhibiting expression of the lysophosphatidic acid receptor EDG2. Cancer Res 2007; 67:11751-9.
15. Fournier HN, Dupe-Manet S, Bouvard D, Lacombe ML, Marie C, Block MR, Albiges-Rizo C. Integrin cytoplasmic domain-associated protein 1alpha (ICAP-1alpha) interacts directly with the metastasis suppressor nm23-H2, and both proteins are targeted to newly formed cell adhesion sites upon integrin engagement. J Biol Chem 2002; 277:20895-902.
16. D'Angelo A, Garzia L, André A, Carotenuto P, Aglio V, Guardiola O, et al. Prune cAMP phosphodiesterase binds nm23-H1 and promotes cancer metastasis. Cancer Cell 2004; 5:137-49.
17. Du J, Hannon GJ. The centrosomal kinase Aurora-A/STK15 interacts with a putative tumor suppressor NM23-H1. Nucleic Acids Res 2002; 30:5465-75. (Pubitemid 36113924)
18. Iwashita S, Fujii M, Mukai H, Ono Y, Miyamoto M. Lbc proto-oncogene product binds to and could be negatively regulated by metastasis suppressor nm23-H2. Biochem Biophys Res Commun 2004; 320:1063-8. (Pubitemid 38916651)
19. Roymans D, Willems R, Vissenberg K, De Jonghe C, Grobben B, Claes P, et al. Nucleoside diphosphate kinase beta (Nm23-R1/NDPKbeta) is associated with intermediate filaments and becomes upregulated upon cAMP-induced differentiation of rat C6 glioma. Exp Cell Res 2000; 261:127-38.
20. Kim MS, Lee EJ, Kim HR, Moon A. p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells. Cancer Res 2003; 63:5454-61.
21. Nosaka K, Kawahara M, Masuda M, Satomi Y, Nishino H. Association of nucleoside diphosphate kinase nm23-H2 with human telomeres. Biochem Biophys Res Commun 1998; 243:342-8. (Pubitemid 28414027)
22. Ma D, Xing Z, Liu B, Pedigo NG, Zimmer SG, Bai Z, et al. NM23-H1 and NM23-H2 repress transcriptional activities of nuclease-hypersensitive elements in the platelet-derived growth factor-A promoter. J Biol Chem 2002; 277:1560-7. (Pubitemid 34968914)
23. Cho SJ, Lee NS, Jung YS, Lee H, Lee KJ, Kim E, Chae SK. Identification of structural domains affecting transactivation potential of Nm23. Biochem Biophys Res Commun 2001; 289:738-43. (Pubitemid 33152295)
24. Murakami M, Meneses PI, Knight JS, Lan K, Kaul R, Verma SC, Robertson ES. Nm23-H1 modulates the activity of the guanine exchange factor Dbl-1. Int J Cancer 2008; 123:500-10. (Pubitemid 351898406)
25. Lee E, Jeong J, Kim SE, Song EJ, Kang SW, Lee KJ. Multiple functions of Nm23-H1 are regulated by oxido-reduction system. PLoS One 2009; 4:7949.
26. Choudhuri T, Verma SC, Lan K, Robertson ES. Expression of alphaV integrin is modulated by Epstein-Barr virus nuclear antigen 3C and the metastasis suppressor Nm23-H1 through interaction with the GATA-1 and Sp1 transcription factors. Virology 2006; 351:58-72. (Pubitemid 44041081)
27. Kaul R, Verma SC, Murakami M, Lan K, Choudhuri T, Robertson ES. Epstein-Barr virus protein can upregulate cyclo-oxygenase-2 expression through association with the suppressor of metastasis Nm23-H1. J Virol 2006; 80:1321-31. (Pubitemid 43134089)
28. Kuppers DA, Lan K, Knight JS, Robertson ES. Regulation of matrix metalloproteinase 9 expression by Epstein-Barr virus nuclear antigen 3C and the suppressor of metastasis Nm23-H1. J Virol 2005; 79:9714-24. (Pubitemid 41022314)
29. Mechta F, Lallemand D, Pfarr CM, Yaniv M. Transformation by ras modifies AP1 composition and activity. Oncogene 1997; 14:837-47.
30. Tapias A, Ciudad CJ, Roninson IB, Noe V. Regulation of Sp1 by cell cycle related proteins. Cell Cycle 2008; 7:2856-67.
31. Jung H, Seong HA, Ha H. NM23-H1 tumor suppressor and its interacting partner STRAP activate p53 function. J Biol Chem 2007; 282:35293-307.
32. Dushin NV, Radysh BB, Gonchar PA, Kutenev AV. Vision disorders as manifestations of transient ischemic attacks in the vertebrobasilar basin. Vestn Oftalmol 2001; 117:27-9.
33. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 2001; 292:727-30.
34. Yu Z, Wang H, Zhang L, Tang A, Zhai Q, Wen J, et al. Both p53-PUMA/NOXA-Bax-mitochondrion and p53-p21cip1 pathways are involved in the CDglyTK-mediated tumor cell suppression. Biochem Biophys Res Commun 2009; 386:607-11.
35. Masuda H, Miller C, Koeffler HP, Battifora H, Cline MJ. Rearrangement of the p53 gene in human osteogenic sarcomas. Proc Natl Acad Sci USA 1987; 84:7716-9.
36. Tee YT, Chen GD, Lin LY, Ko JL, Wang PH. Nm23-H1: a metastasis-associated gene. Taiwan J Obstet Gynecol 2006; 45:107-13.
37. Fan Z, Beresford PJ, Oh DY, Zhang D, Lieberman J. Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor. Cell 2003; 112:659-72. (Pubitemid 36331778)
38. Kaul R, Murakami M, Lan K, Choudhuri T, Robertson ES. EBNA3C can modulate the activities of the transcription factor Necdin in association with metastasis suppressor protein Nm23-H1. J Virol 2009; 83:4871-83.
39. Bosnar MH, Bago R, Gall-Troselj K, Streichert T, Pavelic J. Downstream targets of Nm23-H1: gene expression profiling of CAL 27 cells using DNA microarray. Mol Carcinog 2006; 45:627-33. (Pubitemid 44205102)
40. Zhao H, Jhanwar-Uniyal M, Datta PK, Yemul S, Ho L, Khitrov G, et al. Expression profile of genes associated with antimetastatic gene: nm23-mediated metastasis inhibition in breast carcinoma cells. Int J Cancer 2004; 109:65-70.
41. Horak CE, Lee JH, Elkahloun AG, Boissan M, Dumont S, Maga TK, et al. Nm23-H1 suppresses tumor cell motility by downregulating the lysophosphatidic acid receptor EDG2. Cancer Res 2007; 67:7238-46.
42. Mileo AM, Piombino E, Severino A, Tritarelli A, Paggi MG, Lombardi D. Multiple interference of the human papillomavirus-16 E7 oncoprotein with the functional role of the metastasis suppressor Nm23-H1 protein. J Bioenerg Biomembr 2006; 38:215-25. (Pubitemid 44946229)
43. Lombardi D, Palescandolo E, Giordano A, Paggi MG. Interplay between the antimetastatic nm23 and the retinoblastoma-related Rb2/p130 genes in promoting neuronal differentiation of PC12 cells. Cell Death Differ 2001; 8:470-6. (Pubitemid 32492767)
44. Howlett AR, Petersen OW, Steeg PS, Bissell MJ. A novel function for the nm23-H1 gene: overexpression in human breast carcinoma cells leads to the formation of basement membrane and growth arrest. J Natl Cancer Inst 1994; 86:1838-44.
45. Gervasi F, D'Agnano I, Vossio S, Zupi G, Sacchi A, Lombardi D. nm23 influences proliferation and differentiation of PC12 cells in response to nerve growth factor. Cell Growth Differ 1996; 7:1689-95. (Pubitemid 26415165)
46. Salerno M, Palmieri D, Bouadis A, Halverson D, Steeg PS. Nm23-H1 metastasis suppressor expression level influences the binding properties, stability and function of the kinase suppressor of Ras1 (KSR1) Erk scaffold in breast carcinoma cells. Mol Cell Biol 2005; 25:1379-88. (Pubitemid 40204915)
47. Choudhuri T, Pal S, Agwarwal ML, Das T, Sa G. Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction. FEBS Lett 2002; 512:334-40. (Pubitemid 34164505)
48. Choudhuri T, Pal S, Das T, Sa G. Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner. J Biol Chem 2005; 280:20059-68. (Pubitemid 41379535)
49. Agarwal ML, Taylor WR, Chernov MV, Chernova OB, Stark GR. The p53 network. J Biol Chem 1998; 273:1-4.
50. An R, Chu YL, Tian C, Dai XX, Chen JH, Shi Q, et al. Overexpression of nm23-H1 in HeLa cells provides cells with higher resistance to oxidative stress possibly due to raising intracellular p53 and GPX1. Acta Pharmacol Sin 2008; 29:1451-8.
51. Chen SL, Wu YS, Shieh HY, Yen CC, Shen JJ, Lin KH. p53 is a regulator of the metastasis suppressor gene Nm23-H1. Mol Carcinog 2003; 36:204-14.
52. Wang W, El-Deiry WS. Bioluminescent molecular imaging of endogenous and exogenous p53-mediated transcription in vitro and in vivo using an HCT116 human colon carcinoma xenograft model. Cancer Biol Ther 2003; 2:196-202.
53. Yi F, Saha A, Murakami M, Kumar P, Knight JS, Cai Q, et al. Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities. Virology 2009; 388:236-47.
54. Aiello L, Guilfoyle R, Huebner K, Weinmann R. Adenovirus 5 DNA sequences present and RNA sequences transcribed in transformed human embryo kidney cells (HEK-Ad-5 or 293). Virology 1979; 94:460-9. (Pubitemid 9158080)
55. Cikos S, Bukovska A, Koppel J. Relative quantification of mRNA: comparison of methods currently used for real-time PCR data analysis. BMC Mol Biol 2007; 8:113. (Pubitemid 351234726)
56. Choudhuri T, Verma SC, Lan K, Murakami M, Robertson ES. The ATM/ATR signaling effector Chk2 is targeted by Epstein-Barr virus nuclear antigen 3C to release the G2/M cell cycle block. J Virol 2007; 81:6718-30. (Pubitemid 46878076)
57. Lan K, Choudhuri T, Murakami M, Kuppers DA, Robertson ES. Intracellular activated Notch1 is critical for proliferation of Kaposi's sarcoma-associated herpesvirus-associated B-lymphoma cell lines in vitro. J Virol 2006; 80:6411-9.
58. Lan K, Murakami M, Choudhuri T, Kuppers DA, Robertson ES. Intracellular-activated Notch1 can reactivate Kaposi's sarcoma-associated herpesvirus from latency. Virology 2006; 351:393-403.
59. Verma SC, Lan K, Choudhuri T, Robertson ES. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen modulates K1 expression through its cis-acting elements within the terminal repeats. J Virol 2006; 80:3445-58.